Skip to content

Evaluation of the hemostatic efficacy and safety of molecular sieve hemostatic materials after tooth extraction by a single-group target value method

Evaluation of the hemostatic efficacy and safety of molecular sieve hemostatic materials after tooth extraction by a single-group target value method

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068428
Enrollment
Unknown
Registered
2023-02-17
Start date
2022-09-13
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

impacted tooth

Interventions

Impacted tooth:Molecular sieve hemostatic material

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Understand the whole process of the trial, participate voluntarily and sign the informed consent; 2. Age 18 to 70 years old, both male and female; 3. Those who have no contraindications to tooth extraction.

Exclusion criteria

Exclusion criteria: (1) The patient has received systemic administration that affects coagulation function within 2 weeks before enrollment, including but not limited to warfarin, heparin, hemostatic, hemostatic aromatic acid, thrombin, coagulation factor, aspirin, etc.; (2) Patients diagnosed with hemophilia in the past; (3) Serious heart disease, high blood pressure and diabetes have not been effectively controlled; (4) Women who are in menstruation, pregnancy or breastfeeding; (5) Those who have participated in any clinical trial within 1 month before enrollment; (6) Other circumstances that the investigator considers unable to participate in the clinical trial; (7) Those who have not effectively controlled systemic diseases.

Design outcomes

Primary

MeasureTime frame
Effective rate of hemostasis within 5 minutes;

Countries

China

Contacts

Public ContactFan Yang

Zhejiang Provincial People's Hospital

yangfan@hmc.edu.cn+86 13588139982

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026